title: Prevention of progression in monoclonal gammopathy of undetermined significance.
abstract: Monoclonal gammopathy of undetermined significance (MGUS) is a common premalignant plasma cell proliferative disorder with a lifelong risk of progression to multiple myeloma. Because myeloma is an incurable malignancy, strategies to delay or prevent progression in high-risk patients are of considerable importance.
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, Minnesota 55905, USA. rajkumar.vincent@mayo.edu
authors.forename: S Vincent
authors.initials: SV
authors.lastname: Rajkumar
mesh_terms: D018450:Disease Progression; D006801:Humans; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000235:genetics / Q000473:pathology* / Q000517:prevention & control* / Q000628:therapy; D009101:Multiple Myeloma / Q000235:genetics / Q000473:pathology* / Q000517:prevention & control* / Q000628:therapy; D012307:Risk Factors